definiens: shall mean those Patents Controlled as of the Effective Date or hereafter during the Term by Regeneron or any of its Affiliates ( other than by operation of the lic ense in ARTICLE XII and other than the Joint Patent Rights and the Regeneron Manufacturing Patents ) that inclu de at least one ( 1 ) Valid Claim that, absent a license fr om Regeneron or any of its Affiliates, would be inf ringed ( or, in the case of a Valid Claim that has not yet issued, would infringe such Valid Claim if it were to issue ) by the use, sale or offer for sale ( including Commercialization ), or import of the Product in the Field in the Ter ritory by [COMPANY], including any Patent that claims any Product Inform ation or Product Invention but excluding any Regene ron Manufacturing Patents . 1.142 shall me an Regeneron Patent Rights that claim the composition of matter of, or a pharmaceutical prepa ration that includes as its sole active ingredient, any Competing Product ( including the Product ), or any method of u se of any Competing Product ( including the Product ), including any Regeneron Patent Right that claims any Product Information or Product Invention . Schedule 1.142 li sts all of the Regeneron Product Patent Rights in existence as of the Effective Date